Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA – an observational, 2 phase, patient reported outcomes study

BACKGROUND: We designed the PROXIMA study (Patient-Reported Outcomes and Xolair(®) In the Management of Asthma) to determine the proportion of patients with severe asthma sensitive to perennial allergens, and to evaluate asthma control and treatment adherence up to 12 months in patients treated with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Mol Allergy
Main Authors: Canonica, Giorgio Walter, Bartezaghi, Marta, Marino, Raffaele, Rigoni, Laura
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494726/
https://ncbi.nlm.nih.gov/pubmed/26155196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-015-0019-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares